Valuation: Cegedim

Market Cap 141M 161M 130M 120M 226M 15.45B 230M 1.55B 608M 7.57B 604M 591M 26.06B P/E 2026 *
6.97x
P/E 2027 * 4.64x
Enterprise Value 319M 365M 295M 272M 513M 35.04B 522M 3.51B 1.38B 17.16B 1.37B 1.34B 59.07B EV / Sales 2026 *
0.48x
EV / Sales 2027 * 0.43x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-15.14%
1 week+14.62%
Current month+15.28%
1 month+4.20%
3 months-10.66%
6 months-12.27%
Current year-9.33%
1 month 10.54
Extreme 10.54
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
22.2
5 years 8.6
Extreme 8.6
29.75
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Change 5-day change 1-year change 3-year change Capi.($)
-56.91%+14.62% - - 160M
-1.30%-8.43%-43.44%+8.72% 379B
-2.84%-4.99%-47.02%+6.22% 187B
-4.79%-4.43%-44.99%-8.84% 115B
-4.15%-4.26%-45.02%+1.06% 42.8B
+5.83%-0.09%-78.43%+111.99% 32.38B
-4.58%-6.26%-21.21%+47.84% 29.64B
-0.02%+0.96%-32.81%+19.20% 17.37B
-0.77%-3.31%-35.22%-2.72% 12.19B
-0.02%+2.40%-36.83%+77.95% 11.68B
Average -2.81%-0.82%-42.77%+29.05% 91.89B
Weighted average by Cap. -2.09%-3.48%-44.68%+11.80%

Financials

2026 *2027 *
Net sales 660M 756M 611M 564M 1.06B 72.59B 1.08B 7.28B 2.86B 35.55B 2.84B 2.78B 122B 681M 779M 630M 582M 1.1B 74.87B 1.12B 7.51B 2.95B 36.66B 2.93B 2.86B 126B
Net income 21.25M 24.32M 19.64M 18.15M 34.18M 2.34B 34.8M 234M 91.91M 1.14B 91.34M 89.32M 3.94B 30.58M 35M 28.27M 26.12M 49.19M 3.36B 50.08M 337M 132M 1.65B 131M 129M 5.67B
Net Debt 178M 204M 165M 152M 287M 19.58B 292M 1.96B 771M 9.59B 766M 749M 33.01B 150M 171M 138M 128M 241M 16.46B 245M 1.65B 648M 8.06B 644M 629M 27.75B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
26-07-07 €10.60 -.--% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
10.24EUR
Average target price
15.00EUR
Spread / Average Target
+46.48%

Quarterly revenue - Rate of surprise